C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/16 (2006.01) A61K 39/21 (2006.01) C12N 15/863 (2006.01)
Patent
CA 2578403
The invention provides modified vaccinia Ankara (MVA), a replication-deficient strain of vaccinia virus, expressing human immunodeficiency virus (HIV) env, gag, and pol genes.
L'invention concerne un virus de la vaccine Ankara (MVA) modifiée, souche à déficience de réplication du virus de la vaccine, exprimant les gènes env, gag et pol du VIH.
Moss Bernard
Robinson Harriet L.
Wyatt Linda S.
Emory University
National Institutes Of The Government Of The United States Of America As Represented By
Smart & Biggar
LandOfFree
Recombinant mva viruses expressing clade a/g, clade b, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant mva viruses expressing clade a/g, clade b, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant mva viruses expressing clade a/g, clade b, and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1853264